top of page
Management and prognostic markers in patients with autoimmune encephalitis
Prognosticating autoimmune encephalitis: A systematic review
A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis
Patient characteristics and outcome associations in AMPA receptor encephalitis
Prediction of neutrophil-to-lymphocyte ratio in the diagnosis and progression of autoimmune encephalitis
Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis
In the Clinic-Autoimmune Encephalitis: Persistent Cognitive, Neuropsychological Deficits After Anti-NMDAR Encephalitis Require Therapy, Study Suggests
Long-term neuropsychological outcome following pediatric anti-NMDAR encephalitis
Syndrome and outcome of antibody‐negative limbic encephalitis
Clinical Characteristics and Prognosis of Severe Anti-N-methyl-D-aspartate Receptor Encephalitis Patients
Elevated LGI1‐IgG CSF index predicts worse neurological outcome
High albumin level is a predictor of favorable response to immunotherapy in autoimmune encephalitis
Anti-LGI1–associated cognitive impairment Presentation and long-term outcome
Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long‐term outcome in patients with autoimmune encephalitis
Autoimmune Encephalitis in the ICU: Serological Spectrum, Clinical Courses, Complications and Outcomes
Gly receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes
Limbic encephalitis: Clinical spectrum and long-term outcome from a developing country perspective
Treatment and prognostic factors for long-term outcome in patients with anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis: a cohort study
bottom of page